Inflammatory Cytokines in Symptom Production in Multiple Myeloma
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00688168|
Recruitment Status : Active, not recruiting
First Posted : June 2, 2008
Last Update Posted : January 25, 2018
|Condition or disease||Intervention/treatment|
|Multiple Myeloma||Behavioral: Questionnaire Behavioral: Neurocognitive Testing Behavioral: Neurosensory Testing|
If you agree to take part in this study, you will complete 5 questionnaires during a regularly scheduled clinic visit. These questionnaires will measure pain and other symptoms, such as your mood and quality of life. You will also be asked to give a tissue sample by inserting a swab into your mouth and rubbing firmly against the inside of your cheek or underneath your lower or upper lip for about a minute at most. Completing the 5 questionnaires and the swab sample collection takes about 30 minutes in total.
This is an investigational study.
Up to 500 patients will take part in the cross-sectional phase of this study. All will be enrolled at MD Anderson.
|Study Type :||Observational|
|Estimated Enrollment :||625 participants|
|Official Title:||Identifying the Role of Inflammatory Cytokines in Symptom Production in Multiple Myeloma|
|Actual Study Start Date :||May 2008|
|Estimated Primary Completion Date :||May 2019|
|Estimated Study Completion Date :||May 2020|
Patients diagnosed with multiple myeloma (MM) complete questionnaires with Neurocognitive Testing and Neurosensory Testing
Questionnaires measuring pain and other symptoms, mood, and quality of life.
Other Name: SurveyBehavioral: Neurocognitive Testing
A neurocognitive exam (tests to check your memory and thinking abilities, for example) will be performed.Behavioral: Neurosensory Testing
Neurosensory testing will be performed to find out how sensitive you are to things such as touch, coolness, warmth, pinprick on the finger, and squeezing of the skin on the finger, hand, or arm.
- Multiple myeloma module of MDASI (MDASI-MM) Questionnaire [ Time Frame: Baseline with 12 Month Longitudinal Assessment ]
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00688168
|United States, Texas|
|University of Texas MD Anderson Cancer Center|
|Houston, Texas, United States, 77030|
|Principal Investigator:||Xin Shelley Wang, MD||M.D. Anderson Cancer Center|